Tami T. Martin

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

SUPN

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2021	Supernus Pharmaceuticals, Inc. (SUPN)	R.N., Esq. Senior Vice President, Regulatory Affairs James P. Kelly Former Executive Vice President, Chief Financial Officer	$336,200	—	$45,675	$288,981	$129,700	$42,601	$843,157
2020	Supernus Pharmaceuticals, Inc. (SUPN)	R.N., Esq. Senior Vice President, Regulatory Affairs James P. Kelly Former Executive Vice President, Chief Financial Officer	$326,401	—	—	$309,438	$131,200	$37,598	$804,637
2019	Supernus Pharmaceuticals, Inc. (SUPN)	R.N., Esq. Senior Vice President, Regulatory Affairs James P. Kelly Former Executive Vice President, Chief Financial Officer	$316,891	—	—	$424,540	$91,400	$41,988	$874,819
2018	Supernus Pharmaceuticals, Inc. (SUPN)	R.N., Esq. Senior Vice President, Regulatory Affairs	$307,661	—	—	$278,326	$98,622	$40,430	$725,039
2017	Supernus Pharmaceuticals, Inc. (SUPN)	R.N., Esq. Senior Vice President, Regulatory Affairs	$298,700	—	—	$244,719	$84,413	$43,125	$670,957

No earnings-call appearances or filed executive changes recorded yet.